Chamber(US) | $60,000,000 | (Feb 5, 2026)
Stratus Medical | $10,000,000 | (Feb 5, 2026)
beHuman Corp. | $4,000,000 | (Feb 5, 2026)
Ridge Bio
United States
- Palo Alto, CA
- 10/09/2025
- Seed
- $25,000,000
Ridge Biotechnologies is pioneering AI-based enzyme and targeted drug design to power the next wave of precision therapeutics.
Led by a collection of established biotech entrepreneurs and faculty from top institutions, we use proprietary machine learning models informed by high-throughput cell-free experimentation for a wide range of applications in antibody-drug conjugates (ADCs), conditionally active prodrugs, in vivo CART therapies, targeted nucleic acid delivery, radiotherapies, and enzyme-based therapeutics.
Our current product lines include NativeLink enzymes that enable precision bioconjugation including construction of ADCs and Antibody-oligonucleotide conjugates, ProTrigger linkers that provide tissue and disease-specific activation and release of diverse payloads and prodrugs, and new classes of enzyme-based Catalytic Medicines.
We are focused on enabling our partners to build better drugs for patients.
- Industry Biotechnology Research
- Website https://ridgebio.com/
- LinkedIn https://www.linkedin.com/company/ridge-bio/
Boomband | $4,000,000 | (Feb 5, 2026)
Bedrock Robotics | $270,000,000 | (Feb 5, 2026)
Fibr AI | $7,500,000 | (Feb 5, 2026)
Expert Intelligence™ | $4,700,000 | (Feb 5, 2026)
Positron AI | $230,000,000 | (Feb 5, 2026)
OneDome | $25,000,000 | (Feb 4, 2026)
Naoma AI | $440,000 | (Feb 4, 2026)
MaiaEdge | $20,000,000 | (Feb 4, 2026)
Arbor(US) | $6,300,000 | (Feb 4, 2026)